By blocking the CXCL12/CXCR4 pathway, prostate cancer bone metastasis was significantly suppressed, supporting the hypothesis that prostate tumors metastasize to the bone by adopting this bone-homing signaling pathway. This evidence concerns the gene CXCL12 and prostate carcinoma.